Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) is an Israeli technology company that develops three-dimensional (3D) perception systems and cellular-based accident-prevention solutions for the automotive, defense, agriculture, and heavy-equipment industries. The American Depositary Shares (ADSs) trade at roughly $0.65, leaving investors to ask whether a recovery to the $1.00 level is realistic. That figure is not a Wall Street consensus; it reflects a widely discussed technical and regulatory milestone rather than an analyst-derived price target.
FRSX does not have a meaningful multi-analyst consensus. Public data shows roughly one analyst price target of $4.00 with a Buy rating, but that single figure is more than five times the current price and does not provide a credible near-term benchmark. MarketBeat lists no usable consensus price target for the name. Because a single, stale-looking target is insufficient for a reliable aggregate, the $1.00 level is used instead as a fallback objective drawn from identifiable public discussion: the psychological round-number level and Nasdaq's $1.00 minimum bid price requirement for continued listing. This is a realistic milestone that is publicly discussed, sits well above the current price, and is not unrealistically distant.
At a latest verified price of approximately $0.65, moving to $1.00 implies upside of about 54% — a substantial percentage move for any security, though only about $0.35 in absolute terms for this sub-dollar stock. The path would depend on restoring investor confidence after a steep decline. The shares have traded in a roughly $0.61 to $7.00 range over the past year and have been subject to two reverse splits — a one-for-seven split in August 2025 and a one-for-three split in February 2026 — undertaken to help maintain Nasdaq listing compliance. With a market capitalization of only a few million dollars, the stock is highly sensitive to sentiment and news flow.
The company's technology is its principal asset. Foresight's QuadSight multi-spectral vision system and its Eye-Net Protect cellular-based V2X (vehicle-to-everything) solution target growing ADAS and autonomous-driving markets. Partnerships, including a previously announced cooperation with Tata Elxsi to develop stereo-vision ADAS solutions for the Indian market, provide potential commercial validation. Any new contracts, revenue-generating collaborations, or licensing agreements could re-rate a stock that currently has almost no revenue base. A tightening of supply or renewed retail interest in small-cap automotive technology names could also support a rebound toward the psychological $1.00 level.
The balance sheet and operating history present the largest obstacles. FRSX has generated minimal revenue — in the hundreds of thousands of dollars on a trailing basis — while posting persistent net losses and negative EPS (earnings per share). Continued cash burn raises the prospect of additional capital raises, which can dilute existing holders and pressure the share price. The repeated reverse splits signal ongoing difficulty sustaining a compliant bid price, and a stock that has fallen sharply from its 52-week high faces technical and psychological resistance on any recovery. Competition in ADAS from well-capitalized suppliers, along with the inherent uncertainty of a micro-cap ADR, could keep the shares below $1.00.
From a market-structure perspective, the $0.61 area near the 52-week low acts as a meaningful support level, while the $1.00 mark is both a psychological round number and a regulatory threshold tied to Nasdaq listing rules. Any move toward $1.00 would first need to clear the sub-dollar trading range, and the wide gap to the 52-week high near $7.00 illustrates how far sentiment has deteriorated. The very low trading volume and small float also mean that price moves can be outsized in either direction.
Analyst price targets typically reflect a roughly 12-month research horizon, but with only one target available for FRSX, no dependable timeline can be inferred. Investors should monitor upcoming earnings and any guidance, announcements of new partnerships or customer contracts, cash position and financing activity, and whether the company takes further action related to Nasdaq listing requirements. Changes to the single published analyst target, should coverage expand, would also be relevant to the stock forecast.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly traded micro-cap like FRSX, automated signals can help traders track shifts in momentum and sentiment without watching every tick. Traders use these signals to discover opportunities, monitor existing positions, and spot changing trends more efficiently. Explore the AI Daily Buy/Sell Signals to see how they can complement your own research.
The question of whether FRSX can reach $1.00 hinges on a roughly 54% recovery from the current price, and that target is a publicly discussed regulatory and psychological milestone rather than an analyst consensus. The company's ADAS and vision technology and its partnerships are genuine sources of potential upside, but persistent losses, minimal revenue, cash burn, and repeated reverse splits weigh heavily on the outlook. With essentially one far-above-market analyst target available, there is little independent price validation. Investors should focus on new commercial agreements, funding developments, and listing-status actions, while recognizing that a move to $1.00 is possible but far from assured.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that FRSX and ALV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FRSX and ALV's prices will move in lockstep.
| Ticker / NAME | Correlation To FRSX | 1D Price Change % | ||
|---|---|---|---|---|
| FRSX | 100% | +8.81% | ||
| ALV - FRSX | 30% Poorly correlated | +0.70% | ||
| MOD - FRSX | 30% Poorly correlated | +9.87% | ||
| MLR - FRSX | 30% Poorly correlated | +4.97% | ||
| PHIN - FRSX | 25% Poorly correlated | +2.02% | ||
| CVGI - FRSX | 24% Poorly correlated | +2.22% | ||
More | ||||
| Ticker / NAME | Correlation To FRSX | 1D Price Change % |
|---|---|---|
| FRSX | 100% | +8.81% |
| Producer Manufacturing category (348 stocks) | 2% Poorly correlated | -1.29% |